TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes

Journal of Dermatological Science

Volumn 58, Issue 2, 2010, Pages 97-104

  Räsänen, Kati ^a   Vaheri, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Carcinogenesis; Cyclooxygenase 2; Epithelial mesenchymal transition; Keratinocyte; Migration; Transforming growth factor

Indexed keywords

CYCLOOXYGENASE 2; PROTEIN ZO1; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ARTICLE; CANCER CELL; CELL ASSAY; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CHEMOTAXIS; CONTROLLED STUDY; ENZYME INDUCTION; EPITHELIAL MESENCHYMAL TRANSITION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN CARCINOGENESIS;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHEMOTAXIS; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MESODERM; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 77952238223     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.03.002     Document Type: Article

References (46)

1. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-1428.
2. Guarino M., Rubino B., Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007, 39:305-318.
3. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 2009, 119:1429-1437.
4. Zhang L., Deng M., Parthasarathy R., Wang L., Mongan M., Molkentin J.D., et al. MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration. Mol Cell Biol 2005, 25:60-65.
5. Boukamp P., Stanbridge E.J., Foo D.Y., Cerutti P.A., Fusenig N.E. c-ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 1990, 50:2840-2847.
6. Fusenig N.E., Boukamp P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 1998, 23:144-158.
7. Massague J. TGFbeta in cancer. Cell 2008, 134:215-230.
8. Davies M., Robinson M., Smith E., Huntley S., Prime S., Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, smad and AP-1 signalling pathways. J Cell Biochem 2005, 95:918-931.
9. Wilkins-Port C.E., Ye Q., Mazurkiewicz J.E., Higgins P.J. TGF-beta1 + EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. Cancer Res 2009, 69:4081-4091.
10. Guo Y.S., Chen Z., Wen X.D., Ko T.C., Townsend C.M., Hellmich M.R. Synergistic regulation of COX-2 expression by bombesin and transforming growth factor-beta. Dig Dis Sci 2008, 53:2045-2052.
11. Neil J.R., Johnson K.M., Nemenoff R.A., Schiemann W.P. Cox-2 inactivates smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. Carcinogenesis 2008, 29:2227-2235.
12. Wang M.T., Honn K.V., Nie D. Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Rev 2007, 26:525-534.
13. Greenhough A., Smartt H.J., Moore A.E., Roberts H.R., Williams A.C., Paraskeva C., et al. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009, 30:377-386.
14. Vaheri A., Enzerink A., Räsänen K., Salmenperä P., Nemosis A novel way of fibroblast activation, in inflammation and cancer. Exp Cell Res 2009, 315:1633-1638.
15. Räsänen K., Salmenperä P., Baumann M., Virtanen I., Vaheri A. Nemosis of fibroblasts is inhibited by benign HaCaT keratinocytes but promoted by malignant HaCaT cells. Mol Oncol 2008, 2:340-348.
16. Räsänen K, Vaheri A. Proliferation and motility of HaCaT keratinocyte derivatives is enhanced by fibroblast nemosis. Exp Cell Res, in press, doi:10.1016/j.yexcr.2010.01.020.
17. Virtanen I., Miettinen M., Lehto V.P., Kariniemi A.L., Paasivuo R. Diagnostic application of monoclonal antibodies to intermediate filaments. Ann NY Acad Sci 1985, 455:635-648.
18. Vartio T., Laitinen L., Narvanen O., Cutolo M., Thornell L.E., Zardi L., et al. Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 1987, 88:419-430.
19. Geback T., Schulz M.M., Koumoutsakos P., Detmar M. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. BioTechniques 2009, 46:265-274.
20. Davies M., Paterson I.C., Ganapathy A., Prime S.S. Cell death induced by N-(4-hydroxyphenyl) retinamide in human epidermal keratinocytes is modulated by TGF-beta and diminishes during the progression of squamous cell carcinoma. Int J Cancer 2006, 119:2803-2811.
21. Funderburgh J.L., Funderburgh M.L., Mann M.M., Corpuz L., Roth M.R. Proteoglycan expression during transforming growth factor β-induced keratocyte-myofibroblast transdifferentiation. J Biol Chem 2001, 276:44173-44178.
22. Herfs M., Hubert P., Kholod N., Caberg J.H., Gilles C., Berx G., et al. Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression. Am J Pathol 2008, 17:1391-1402.
23. Zavadil J., Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24:5764-5774.
24. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753-791.
25. Li A.G., Lu S.L., Han G., Hoot K.E., Wang X.J. Role of TGFbeta in skin inflammation and carcinogenesis. Mol Carcinog 2006, 45:389-396.
26. Oft M., Akhurst R.J., Balmain A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 2002, 4:487-494.
27. Datto M.B., Li Y., Panus J.F., Howe D.J., Xiong Y., Wang X.F. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995, 92:5545-5549.
28. Pietenpol J.A., Holt J.T., Stein R.W., Moses H.L. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 1990, 87:3758-3762.
29. Cerezo A., Kalthoff H., Schuermann M., Schafer B., Boukamp P. Dual regulation of telomerase activity through c-myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci 2002, 115:1305-1312.
30. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001, 29:117-129.
31. Missero C., Ramon y Cajal S., Dotto G.P. Escape from transforming growth factor beta control and oncogene cooperation in skin tumor development. Proc Natl Acad Sci USA 1991, 88:9613-9617.
32. Gold L.I., Jussila T., Fusenig N.E., Stenback F. TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis. J Pathol 2000, 190:579-588.
33. Game S.M., Huelsen A., Patel V., Donnelly M., Yeudall W.A., Stone A., et al. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes. Int J Cancer 1992, 52:461-470.
34. Xie L., Law B.K., Chytil A.M., Brown K.A., Aakre M.E., Moses H.L. Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 2004, 6:603-610.
35. Han G., Lu S.L., Li A.G., He W., Corless C.L., Kulesz-Martin M., et al. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 2005, 115:1714-1723.
36. Ikuta T., Kawajiri K. Zinc finger transcription factor slug is a novel target gene of aryl hydrocarbon receptor. Exp Cell Res 2006, 312:3585-3594.
37. Tomakidi P., Stark H.J., Herold-Mende C., Bosch F.X., Steinbauer H., Fusenig N.E., et al. Discriminating expression of differentiation markers evolves in transplants of benign and malignant human skin keratinocytes through stromal interactions. J Pathol 2003, 200:298-307.
38. Szell M., Bata-Csorgo Z., Koreck A., Pivarcsi A., Polyanka H., Szeg C., et al. Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin. J Invest Dermatol 2004, 123:537-546.
39. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
40. Bachmeier B.E., Boukamp P., Lichtinghagen R., Fusenig N.E., Fink E. Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol Chem 2000, 381:497-507.
41. Broom O.J., Massoumi R., Sjolander A. Alpha2beta1 integrin signalling enhances cyclooxygenase-2 expression in intestinal epithelial cells. J Cell Physiol 2006, 209:950-958.
42. Takaoka K., Kishimoto H., Segawa E., Hashitani S., Zushi Y., Noguchi K., et al. Elevated cell migration, invasion and tumorigenicity in human KB carcinoma cells transfected with COX-2 cDNA. Int J Oncol 2006, 29:1095-1101.
43. Lee E.J., Choi E.M., Kim S.R., Park J.H., Kim H., Ha K.S., et al. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells. Exp Mol Med 2007, 39:469-476.
44. Banu S.K., Lee J., Speights V.O., Starzinski-Powitz A., Arosh J.A. Cyclooxygenase-2 regulates survival, migration, and invasion of human endometriotic cells through multiple mechanisms. Endocrinology 2008, 149:1180-1189.
45. Johansson N., Ala-aho R., Uitto V., Grenman R., Fusenig N.E., Lopez-Otin C., et al. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 2000, 113(Pt 2):227-235.
46. Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009, 30:1073-1081.